Effect of delaying surgery by more than 10 weeks after neoadjuvant therapy in rectal cancer: a single institution experience

Autor: Piva, Cristina, Panier Suffat, Luca, Petrucci, Edoardo T. F., Manuguerra, Giovanna, Vittone, Federico, Cante, Domenico, Ferrario, Silvia, Paolini, Marina, Radici, Lorenzo, Vellani, Giorgio, La Porta, Maria R.
Zdroj: Updates in Surgery; 20210101, Issue: Preprints p1-7, 7p
Abstrakt: The optimal timing of surgery after neoadjuvant chemoradiotherapy (CRT) in locally advanced rectal cancer is still controversial. Aim of this study was to evaluate the effect of increasing time interval between the end of CRT and surgery on pathological outcomes. This is a retrospective analysis on 114 patients treated with long-course neoadjuvant RT with or without chemotherapy between January 2005 and September 2020. 43 patients underwent surgery within 10 weeks from the end of CRT (1st group), whereas 71 patients underwent total mesorectal excision with a time interval equal or greater than 10 weeks (2nd group). Primary endpoint was pCR (pathological complete response). Secondary endpoints were near pCR (ypT0–1 N0), tumor downstaging (ypT less than cT), nodal downstaging (ypN less than cN), and overall response comparing clinical with pathological TN stage. Overall, the pCR rate was 8.8%, whereas we observed no significantly difference in primary endpoint between the two groups. Considering near pCR, a trend toward significant difference in favor of 2nd group was seen (p= 0.072). Tumor and nodal downstaging rates were 39.5%, 41.9%, 59.2%, and 56.3% in the 1st and 2nd group, respectively, with a statistically significant difference for T category (p= 0.042). Overall response rates (TN stage) showed a trend toward significant difference in favor of patients of the ≥ 10 week group (p= 0.059). Our study suggests that a prolonged time interval between the end of CRT and surgery (≥ 10 weeks) increases pathological response rates.
Databáze: Supplemental Index
Externí odkaz: